{"url_path":"/sec/imdx/13dg/2026-04-27/000091957426002415","section_key":"body","section_title":"SCHEDULE 13D/A body","topic":"sec","document":{"doc_type":"SCHEDULE 13D/A","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1278386/0000919574-26-002415-index.html","accession_number":"0000919574-26-002415","cik":"0001642380","ticker":"IMDX","issuer_name":"Insight Molecular Diagnostics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1642380/0000919574-26-002415-index.html","primary_entity_key":"0001278386","primary_entity_name":"BROADWOOD PARTNERS, L.P."},"word_count":87,"has_tables":true,"body_markdown":"EX-99\n2\nd12145300_ex99-a.htm\n\nExhibit A\n\nJOINT FILING AGREEMENT\n\nThe undersigned agree that\nthis Amendment No. 14 to Schedule 13D, dated April 27, 2026, relating to the Common Stock, no par value, of Insight Molecular Diagnostics\nInc. shall be filed on behalf of the undersigned.\n\nDated: April 27, 2026\n\nBroadwood Partners, L.P.\n\nBy:\nBroadwood Capital, Inc.\n\nBy:\n/s/ Neal C. Bradsher\n\nName:\nNeal C. Bradsher\n\nTitle:\nPresident\n\nBroadwood Capital, Inc.\n\nBy:\n/s/ Neal C. Bradsher\n\nName:\nNeal C. Bradsher\n\nTitle:\nPresident\n\n/s/ Neal C. Bradsher\n\nNeal C. Bradsher"}